Fatal hepatitis B reactivation due to everolimus in metastatic breast cancer: case report and review of literature Eleonora TeplinskyDerrick CheungKomal Jhaveri Review 04 September 2013 Pages: 167 - 172
Screening for sexual dysfunction in women diagnosed with breast cancer: systematic review and recommendations Iris BartulaKerry A. Sherman Review Open access 08 September 2013 Pages: 173 - 185
No evidence for shedding of circulating tumor cells to the peripheral venous blood as a result of mammographic breast compression Daniel FörnvikIngvar AnderssonKristina Aaltonen Preclinical Study Open access 29 August 2013 Pages: 187 - 195
Targeted elimination of breast cancer cells with low proteasome activity is sufficient for tumor regression Erina VlashiChann LagadecFrank Pajonk Preclinical Study 08 September 2013 Pages: 197 - 203
BRCA1 promoter methylation is a marker of better response to anthracycline-based therapy in sporadic TNBC T. IgnatovA. PoehlmannJ. Bischoff Preclinical study 13 September 2013 Pages: 205 - 212
Predictive and prognostic significance of cytoplasmic expression of ELAV-like protein HuR in invasive breast cancer treated with neoadjuvant chemotherapy Jun WangDali LiYun Wu Preclinical study 14 September 2013 Pages: 213 - 224
The effect of country wealth on incidence of breast cancer Mario Coccia Preclinical study 15 September 2013 Pages: 225 - 229
Short telomeres are frequent in hereditary breast tumors and are associated with high tumor grade Beatriz Martinez-DelgadoMercedes GallardoJavier Benitez Preclinical study 15 September 2013 Pages: 231 - 242
Serum concentrations of tamoxifen and its metabolites increase with age during steady-state treatment Ernst A. LienHåvard SøilandJennifer Gjerde Clinical trial Open access 01 September 2013 Pages: 243 - 248
Pre-chemotherapy 18F-FDG PET/CT upstages nodal stage in stage II–III breast cancer patients treated with neoadjuvant chemotherapy Bas B. KoolenRenato A. Valdés OlmosPaula H. M. Elkhuizen Clinical trial 04 September 2013 Pages: 249 - 254
Neoadjuvant bevacizumab: surgical complications of mastectomy with and without reconstruction Kari Joanne KansalLaura Stewart DominiciMehra Golshan Clinical trial 13 September 2013 Pages: 255 - 259
Ductal carcinoma in situ: knowledge of associated risks and prognosis among Latina and non-Latina white women Aparna R. ParikhCelia Patricia KaplanLeah S. Karliner Epidemiology 01 September 2013 Pages: 261 - 268
Role of maximum standardized uptake value in fluorodeoxyglucose positron emission tomography/computed tomography predicts malignancy grade and prognosis of operable breast cancer: a multi-institute study Takayuki KadoyaKenjiro AogiMorihito Okada Epidemiology Open access 13 September 2013 Pages: 269 - 275
Use of complementary and alternative medicine (CAM) and changes in depressive symptoms from 3 to 15 months after surgery for primary breast cancer: results from a nationwide cohort study Christina Gundgaard PedersenSøren ChristensenRobert Zachariae Epidemiology 14 September 2013 Pages: 277 - 285
Associations between genetic variants in the TGF-β signaling pathway and breast cancer risk among Hispanic and non-Hispanic white women Stephanie D. BooneKathy B. BaumgartnerMartha L. Slattery Epidemiology 14 September 2013 Pages: 287 - 297
Vegetable protein and vegetable fat intakes in pre-adolescent and adolescent girls, and risk for benign breast disease in young women Catherine S. BerkeyWalter C. WillettGraham A. Colditz Epidemiology 17 September 2013 Pages: 299 - 306
Plasma florescent oxidation products and breast cancer risk: repeated measures in the Nurses’ Health Study Renée T. FortnerShelley S. TworogerA. Heather Eliassen Epidemiology 18 September 2013 Pages: 307 - 316
Sulforaphane inhibits mammary adipogenesis by targeting adipose mesenchymal stem cells Qinglin LiJixiang XiaQun Zhou Brief Report 04 September 2013 Pages: 317 - 324
